Susan Lee will join Goodwin as a Life Sciences and Business Litigation partner in Washington, D.C. with a focus on advising drug and biologic companies on new Food and Drug Administration regulatory and compliance issues. Mitchell Bloom, chair of the firm’s life sciences practice, stated that Lee's broad experience in FDA regulatory strategy, commercialization and issues related to corporate transactions will be invaluable to her clients at all stages of the product and corporation lifecycle. Read the Law360 article here.